Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Abbott Laboratories Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

$7.89 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $12,357 - $14,497	-130 Reduced 52.0%	120 $13,000
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $53,589 - $65,348	-470 Reduced 65.28%	250 $30,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $83,181 - $101,851	720 New	720 $101,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.9 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.6 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.11 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.81 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.33 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Account